A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Advanced Solid Tumors
Interventions
DRUG

TAS-114 + S-1

Trial Locations (1)

277-8577

Site 01, Kashiwanoha, Kashiwa-shi

All Listed Sponsors
lead

Taiho Pharmaceutical Co., Ltd.

INDUSTRY

NCT01610479 - A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter